Key finding
Fasting blood glucose decreased significantly (p = 0.01 within-group effects, p = 0.03 interaction effects).
This study evaluated the effects of combined antioxidant and prebiotic supplementation on type 2 diabetes outcomes, finding significant improvements in fasting plasma glucose and glycated hemoglobin.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Antioxidant/prebiotic supplement, Maltodextrin (control)
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Primary outcome
Fasting Plasma Glucose (FPG)
Comparator
Control Group (CG)
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study evaluated the effects of combined antioxidant and prebiotic supplementation on type 2 diabetes outcomes, finding significant improvements in fasting plasma glucose and glycated hemoglobin.
The findings highlight the potential of dietary supplements in managing type 2 diabetes, which is a growing health concern globally. Effective management strategies can lead to better health outcomes and reduced complications for patients with diabetes. This study provides evidence that combined antioxidant and prebiotic supplementation may serve as a complementary approach to traditional diabetes treatments.
Limited sample size may affect generalizability. Short duration of the study may not capture long-term effects. No assessment of potential confounding factors.
Published in
Publication details and source links for this paper.
Chompoonut T, Juntanee U, Jatuporn P, et al. Therapeutic Effects of Combined Antioxidant and Prebiotic Supplementation on Type 2 Diabetes Outcomes. Nutrients. 2025;17(7):1098. doi:10.3390/nu17071098
Save this study and add notes to your research library.
Fasting plasma glucose decreased by 1.5 mmol/L (p = 0.01).
Glycated hemoglobin decreased by 0.8% (p = 0.004).
Low density lipoprotein decreased by 0.5 mmol/L (p = 0.006).
Glomerular filtration rate improved by 5 mL/min (p = 0.01).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Combined antioxidant/prebiotic supplement, Maltodextrin (control) and Estimated glomerular filtration rate, Fasting Plasma Glucose (FPG), HbA1c, and 2 more.
This study contributes evidence to
Primary intervention
Combined antioxidant/prebiotic supplement
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
8
Evidence pairs
284
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Combined antioxidant/prebiotic supplement → Estimated glomerular filtration rate
Combined antioxidant/prebiotic supplement → Estimated glomerular filtration rate
Evidence profile
Combined antioxidant/prebiotic supplement → Fasting Plasma Glucose (FPG)
Combined antioxidant/prebiotic supplement → Fasting Plasma Glucose (FPG)
Evidence profile
Combined antioxidant/prebiotic supplement → HbA1c
Combined antioxidant/prebiotic supplement → HbA1c
Evidence profile
Combined antioxidant/prebiotic supplement → LDL cholesterol
Combined antioxidant/prebiotic supplement → LDL cholesterol
Evidence profile
Maltodextrin (control) → Estimated glomerular filtration rate
Maltodextrin (control) → Estimated glomerular filtration rate
Evidence profile
Maltodextrin (control) → Fasting blood sugar (FBS)
Maltodextrin (control) → Fasting blood sugar (FBS)
Evidence profile
Maltodextrin (control) → HbA1c
Maltodextrin (control) → HbA1c
Evidence profile
Maltodextrin (control) → LDL cholesterol
Maltodextrin (control) → LDL cholesterol
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Probiotics and Synbiotics and Kidney Function, Probiotics and Synbiotics and Fasting Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies measuring Kidney Function
Measures Kidney Function as a key outcome.
All studies on Probiotics and Synbiotics
Contributes to Probiotics and Synbiotics evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Probiotics and Synbiotics appears to improve HbA1c.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 10 supporting studies with consistent results and a positive effect signal.
Limitations
Probiotics and Synbiotics may improve Fasting Glucose.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 9 supporting studies and existing graph evidence signals.
Limitations
Current evidence does not show a clear benefit of Probiotics and Synbiotics for Kidney Function.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Estimated glomerular filtration rate
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Current evidence does not show a clear benefit of Probiotics and Synbiotics for Adipokine and Angiogenic Markers.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
LDL cholesterol
EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 9 supporting studies and existing graph evidence signals.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
